Simultaneous disease detection system method and devices
US-12092629-B2 · Sep 17, 2024 · US
US2016291001A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016291001-A1 |
| Application number | US-201615186089-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 17, 2016 |
| Priority date | Dec 19, 2013 |
| Publication date | Oct 6, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a sensor for detection of disease markers, and methods for detecting a disease marker, using a conductive hydrogel modified with a biorecognition element.
Opening claim text (preview).
What is claimed is: 1 . A sensor comprising: a substrate; at least one electrode contacting the substrate; a nanoporous membrane covering the electrode; and a biorecognition element selected from the group consisting of a peptide, an antibody, an enzyme, and an aptamer, wherein the biorecognition element is covalently bound to the electrode, or covalently bound to a PEDOT random copolymer embedded within the nanoporous membrane, the PEDOT random copolymer having a structure according to Formula I: wherein each R is independently selected from the group consisting of —OH and the biorecognition element, wherein at least one R is the biorecognition element, and x and y are independently an integer of from about 1 to about 1000, wherein the sum of x and y is an integer of from about 2 to about 1000. 2 . The sensor of claim 1 , wherein the electrode is a micropatterned gold electrode. 3 . The sensor of claim 1 , wherein the sensor comprises a center working electrode, a surrounding counter electrode, and a reference electrode. 4 . The sensor of claim 1 , wherein the biorecognition element is an antibody. 5 . The sensor of claim 1 , wherein the biorecognition element is an aptamer. 6 . The sensor of claim 1 , wherein the biorecognition element is covalently bound to the PEDOT random copolymer embedded within the nanoporous membrane, wherein the nanoporous membrane comprises a PEG hydrogel having PEG chains with a molecular weight of from about 1000 Da to about 10,000 Da. 7 . The sensor of claim 6 , wherein the PEG hydrogel comprises PEG chains having a molecular weight of about 6000 Da. 8 . The sensor of claim 6 , wherein the PEG hydrogel is covalently bound to the substrate. 9 . The sensor of claim 6 , wherein the ratio of x to y is from about 10:1 to about 1:10. 10 . The sensor of claim 1 , wherein the nanoporous membrane is an aluminum oxide membrane. 11 . The sensor of claim 10 , wherein the biorecognition element is covalently linked to the electrode to form a self-assembled monolayer of the biorecognition element on the electrode. 12 . The sensor of claim 11 , wherein the biorecognition element is an aptamer having a redox reporting moiety and a thiol moiety, wherein the thiol moiety is covalently bound to a gold working electrode. 13 . A method for detecting a disease marker in a biological sample comprising contacting a sensor according to claim 1 with the biological sample and detecting the binding of the disease marker to a biorecognition element, thereby detecting the disease marker. 14 . The method of claim 13 , wherein detecting the binding of the disease marker to the biorecognition element comprises measuring the peak reduction current of the PEDOT random copolymer. 15 . The method of claim 13 , wherein the binding of the disease marker to the biorecognition element is detected using square wave voltammetry. 16 . The method of claim 13 , wherein the disease marker is indicative of an infection by tuberculosis or hepatitis C. 17 . A conductive hydrogel comprising: a covalently cross-linked poly(ethylene glycol) (PEG) hydrogel; and a poly(3,4-ethylenedioxythiophene) (PEDOT) random copolymer embedded within the PEG hydrogel, the PEDOT random copolymer having a structure according to Formula I: wherein each R is independently selected from the group consisting of —OH and a biorecognition element selected from the group consisting of a peptide, an antibody, an enzyme, and an aptamer, wherein at least one R is the biorecognition element, and x and y are independently an integer of from about 1 to about 1000, wherein the sum of x and y is an integer of from about 2 to about 1000. 18 . The conductive hydrogel of claim 17 , wherein the PEG hydrogel comprises PEG chains having molecular weights of from about 1000 Da to about 10,000 Da. 19 . The conductive hydrogel of claim 17 , wherein the ratio of x to y is from about 10:1 to about 1:10. 20 . The conductive hydrogel of claim 19 , wherein the covalently cross-linked poly(ethylene glycol) hydrogel is prepared from PEG-diacrylate.
Synthetic resin · CPC title
from Mycobacteriaceae (F) · CPC title
being a redox reaction, e.g. detection by cyclic voltammetry (voltammetry per se G01N27/42, G01N27/48) · CPC title
Infectious diseases, e.g. generalised sepsis · CPC title
IFN-gamma · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.